ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,1,Corneal abrasion,Eye injuries NEC,Injuries NEC,Inj&P,N
6,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
6,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
7,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
8,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
9,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
9,2,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
10,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
11,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
11,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
13,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
13,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
14,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
15,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
15,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
16,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
16,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
16,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
17,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
17,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,3,Headache,Headaches NEC,Headaches,Nerv,N
17,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
18,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
19,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
19,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
19,3,Vasodilation procedure,Vascular therapeutic procedures NEC,Vascular therapeutic procedures,Surg,N
20,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
20,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
20,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
21,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
22,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
23,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
23,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
23,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
24,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
25,1,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
26,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
27,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
27,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
27,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
28,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
29,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
30,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
31,1,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
32,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
32,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
33,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
34,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
34,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
34,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
35,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
36,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
36,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
37,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
37,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
38,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
39,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
39,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
40,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
40,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
41,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
41,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
41,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
41,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
42,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
42,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
43,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
44,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
45,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,2,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
46,1,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
46,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
46,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
47,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
48,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
50,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
51,1,Blood alcohol increased,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
52,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
52,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
53,1,Oral mucosal exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
54,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
55,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
56,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
57,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
58,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
59,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
59,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
59,3,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
60,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
61,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
62,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
63,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
64,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
64,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
65,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
66,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
66,2,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
67,1,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
68,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
70,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
70,2,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
71,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
72,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
72,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
72,3,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
72,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
72,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
72,6,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
73,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
74,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
75,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
76,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
77,1,Breath holding,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
77,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
78,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
79,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
80,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
81,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
81,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
81,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
82,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
83,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
84,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
84,2,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
85,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
86,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
86,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
87,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
88,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
88,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
89,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
89,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
90,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
90,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
91,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
92,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
92,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
93,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
94,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
94,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
95,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
95,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
96,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
96,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
97,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
97,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
97,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
97,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
98,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
99,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
100,1,Sleep talking,Parasomnias,Sleep disorders and disturbances,Psych,N
101,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
102,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
103,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
103,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
103,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
103,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
103,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
104,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
104,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
105,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
106,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
106,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
106,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
106,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
107,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
107,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
108,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
109,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
110,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
110,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
111,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
111,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
111,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
112,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
113,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
114,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
114,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
115,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
115,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
116,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
116,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
116,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
117,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
118,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
118,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
119,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
120,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
120,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
120,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
121,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
122,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
123,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
124,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
125,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
126,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
126,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
127,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
127,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
127,3,Noninfective gingivitis,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
127,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
128,1,Headache,Headaches NEC,Headaches,Nerv,N
128,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
129,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
129,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
130,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
130,2,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
130,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
130,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
131,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
131,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
132,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
132,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
132,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
132,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
133,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
133,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
133,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
133,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
133,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
133,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
133,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
134,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
135,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
135,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
136,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
136,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
137,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
137,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
138,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
139,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
140,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
140,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
141,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
142,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
142,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
142,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
143,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
144,1,Migraine,Migraine headaches,Headaches,Nerv,N
145,1,Accidental poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
146,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
146,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
147,1,5'nucleotidase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
147,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
147,3,Anisochromia,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
147,4,Anisocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
147,5,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
147,6,Bromosulphthalein test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
147,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
147,8,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
147,9,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
147,10,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
147,11,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
147,12,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
147,13,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
147,14,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
147,15,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
147,16,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
147,17,Liver palpable,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
147,18,Liver scan abnormal,Hepatobiliary imaging procedures,Hepatobiliary investigations,Inv,N
147,19,Neutrophil toxic granulation present,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
147,20,Occult blood positive,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
147,21,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
147,22,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
148,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
148,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
148,3,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
148,4,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
148,5,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
148,6,Headache,Headaches NEC,Headaches,Nerv,N
148,7,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
148,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
148,9,Marital problem,Family and partner issues,Family issues,SocCi,N
148,10,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
148,11,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
148,12,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
148,13,Paranoid personality disorder,Personality disorders with eccentric behaviour (Cluster A),Personality disorders and disturbances in behaviour,Psych,N
148,14,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
148,15,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
148,16,Suspiciousness,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
149,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
149,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
149,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
149,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
150,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
151,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
152,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
152,2,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
153,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
154,1,Chemical burn of oral cavity,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
154,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
154,3,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
154,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
154,5,Oral mucosal exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
154,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
154,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
154,8,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
155,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
156,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
156,2,Bronchial disorder,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
156,3,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
156,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
156,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
156,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
156,7,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
156,8,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
156,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
156,10,Nocturnal dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
156,11,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
156,12,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
156,13,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
156,14,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
156,15,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
156,16,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
156,17,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
156,18,Respiratory tract inflammation,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
156,19,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
157,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
157,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
157,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
157,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
158,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
158,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
159,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
160,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
161,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
162,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
162,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
162,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
163,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
163,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
164,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
164,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
165,1,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
165,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
165,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
166,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
166,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
166,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
167,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
167,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
168,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
169,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
170,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
170,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
170,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
170,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
170,5,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
171,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
171,2,Exposure via direct contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
171,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
171,4,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
171,5,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
171,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
172,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
172,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
173,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
173,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
173,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
173,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
173,5,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
173,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
174,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
174,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
175,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
176,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
176,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
177,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
177,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
177,3,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
178,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
178,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
179,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
180,1,Chloropsia,Visual colour distortions,Vision disorders,Eye,N
181,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
182,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
183,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
183,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
184,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
185,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
185,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
186,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
186,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
187,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
187,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
187,3,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
188,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
188,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
188,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
189,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
189,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
190,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
190,2,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
190,3,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
190,4,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
190,5,Application site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
190,6,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
190,7,Application site pain,Application site reactions,Administration site reactions,Genrl,N
190,8,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
190,9,Application site rash,Application site reactions,Administration site reactions,Genrl,N
190,10,Application site scab,Application site reactions,Administration site reactions,Genrl,N
190,11,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
190,12,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
190,13,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
191,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
191,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
191,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
191,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
191,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
191,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
192,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
192,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
192,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
193,1,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
193,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
193,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
193,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
193,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
194,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
195,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
196,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
196,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
196,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
196,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
196,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
197,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
197,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
198,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
199,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
199,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
199,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
199,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
199,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
199,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
199,7,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
200,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
200,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
200,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
201,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
201,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
202,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
202,2,Exposure via ingestion,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
202,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
203,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
204,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
204,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
204,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
205,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
206,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
206,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
206,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
206,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
207,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
207,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
207,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
207,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
208,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
208,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
208,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
209,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
210,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
210,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
210,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
210,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
211,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
211,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
211,3,Product counterfeit,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
211,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
211,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
212,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
212,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
213,1,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
213,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
213,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
214,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
214,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
214,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
215,1,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
215,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
216,1,Migraine,Migraine headaches,Headaches,Nerv,N
216,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
216,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
217,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
218,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
218,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
218,3,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
218,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
219,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
219,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
219,3,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
220,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
221,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
221,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
222,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
223,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
224,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
225,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
225,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
225,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
226,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
226,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
226,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
226,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
227,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
227,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
227,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
228,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
228,2,Application site urticaria,Application site reactions,Administration site reactions,Genrl,N
229,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
229,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
229,3,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
230,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
230,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
231,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
231,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
231,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
231,4,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
231,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
231,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
231,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
231,8,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
231,9,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
232,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
232,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
233,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
233,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
233,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
234,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
234,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
234,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
234,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
235,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
235,2,Lip pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
235,3,Oral pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
235,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
235,5,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
235,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
236,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
236,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
237,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
238,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
238,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
238,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
238,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
238,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
238,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
238,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
238,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
239,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
240,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
240,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
240,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
241,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
242,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
243,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
244,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
244,2,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
244,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
245,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
245,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
245,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
246,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
246,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
246,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
246,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
246,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
246,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
247,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
248,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
249,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
249,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
249,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
250,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
250,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
250,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
250,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
251,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
251,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
251,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
252,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
252,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
252,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
252,4,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
253,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
253,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
253,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
253,4,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
254,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
254,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
255,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
255,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
256,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
257,1,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
257,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
257,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
257,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
258,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
259,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
259,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
260,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
260,2,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
260,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
260,4,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
260,5,Application site pain,Application site reactions,Administration site reactions,Genrl,N
260,6,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
260,7,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
260,8,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
261,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
261,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
262,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
263,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
263,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
264,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
264,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
265,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
265,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
265,3,Headache,Headaches NEC,Headaches,Nerv,N
265,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
265,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
265,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
265,7,Sinus headache,Headaches NEC,Headaches,Nerv,N
265,8,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
265,9,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
266,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
266,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
267,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
267,2,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
267,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
267,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
267,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
267,6,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
267,7,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
267,8,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
267,9,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
267,10,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
267,11,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
268,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
268,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
269,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
269,2,Headache,Headaches NEC,Headaches,Nerv,N
269,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
269,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
269,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
269,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
270,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
270,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
270,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
271,1,Exposure via inhalation,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
271,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
271,3,Headache,Headaches NEC,Headaches,Nerv,N
271,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
271,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
272,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
272,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
272,3,Headache,Headaches NEC,Headaches,Nerv,N
272,4,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
272,5,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
272,6,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
273,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
273,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
274,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
274,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
275,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
275,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
275,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
275,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
276,1,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
276,2,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
277,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
277,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
277,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
278,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
279,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
279,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
280,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
281,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
282,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
282,2,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
283,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
284,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
284,2,Genital erythema,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
284,3,Genital tract inflammation,Reproductive tract infections and inflammations NEC,Reproductive tract disorders NEC,Repro,N
285,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
286,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
287,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
288,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
288,2,Macule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
288,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
288,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
288,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
288,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
289,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
289,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
290,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
290,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
291,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
291,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
291,3,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
291,4,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
291,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
291,6,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
292,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
292,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
293,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
293,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
293,3,Nasal disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
294,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
294,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
294,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
294,4,Vaccination site bruising,Vaccination site reactions,Administration site reactions,Genrl,N
295,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
295,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
296,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
296,2,Grip strength decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
296,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
296,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
296,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
296,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
296,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
296,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
297,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
298,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
299,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
299,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
299,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
299,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
300,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
300,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
300,3,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
300,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
300,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
301,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
301,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
302,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
303,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
303,2,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
303,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
303,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
303,5,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
303,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
303,7,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
304,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
304,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
304,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
304,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
304,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
304,6,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
305,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
305,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
306,1,Vomiting projectile,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
307,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
307,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
307,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
308,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
308,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
308,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
309,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
310,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
310,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
311,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
312,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
312,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
313,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
313,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
314,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
314,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
315,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
316,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
316,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
317,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
317,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
318,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
318,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
319,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
319,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
319,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
320,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
321,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
321,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
322,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
322,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
323,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
323,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
323,3,Exposure via inhalation,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
323,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
323,5,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
323,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
323,7,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
324,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
324,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
324,3,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
324,4,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
324,5,Tongue erythema,Tongue signs and symptoms,Tongue conditions,Gastr,N
325,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
325,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
325,3,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
325,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
326,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
327,1,Hyposmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
327,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
327,3,Sinus congestion,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
327,4,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
328,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
328,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
328,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
328,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
328,5,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
329,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
329,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
329,3,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
329,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
329,5,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
329,6,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
329,7,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
329,8,Suspected product tampering,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
329,9,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
330,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
331,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
331,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
332,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
332,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
332,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
333,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
333,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
333,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
333,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
333,5,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
333,6,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
333,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
333,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
333,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
333,10,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
334,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
334,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
334,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
334,4,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
334,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
334,6,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
335,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
335,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
335,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
335,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
336,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
336,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
336,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
336,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
336,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
336,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
337,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
337,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
337,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
337,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
337,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
338,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
338,2,Exposure via ingestion,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
338,3,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
338,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
338,5,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
338,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
339,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
339,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
340,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
341,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
342,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
342,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
342,3,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
342,4,Paranasal sinus discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
342,5,Product leakage,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
342,6,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
343,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
343,2,Intentional product misuse to child,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
344,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
344,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
345,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
346,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
346,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
346,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
347,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
347,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
348,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
348,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
349,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
350,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
350,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
351,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
351,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
352,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
353,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
354,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
354,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
355,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
356,1,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
357,1,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
357,2,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
358,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
358,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
358,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
359,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
360,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
361,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
362,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
363,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
364,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
364,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
365,1,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
366,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
366,2,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
366,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
367,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
367,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
367,3,Exposure via eye contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
367,4,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
367,5,Eye abrasion,Eye injuries NEC,Injuries NEC,Inj&P,N
367,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
367,7,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
367,8,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
367,9,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
367,10,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
368,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
369,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
370,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
370,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
370,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
370,4,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
370,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
370,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
371,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
372,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
373,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
373,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
373,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
373,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
374,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
374,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
374,3,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
375,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
376,1,Headache,Headaches NEC,Headaches,Nerv,N
377,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
378,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
378,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
378,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
379,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
379,2,Headache,Headaches NEC,Headaches,Nerv,N
379,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
379,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
379,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
380,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
381,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
381,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
382,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
382,2,Suspected product contamination,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
383,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
383,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
383,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
383,4,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
383,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
384,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
385,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
385,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
386,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
386,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
386,3,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
386,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
386,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
387,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
388,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
388,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
388,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
388,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
388,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
389,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
389,2,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
389,3,Intentional product misuse to child,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
390,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
391,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
392,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
393,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
394,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
395,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
395,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
396,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
396,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
397,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
397,2,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
398,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
398,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
398,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
398,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
398,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
399,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
400,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
400,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
400,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
400,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
400,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
400,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
401,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
402,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
403,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
403,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
403,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
404,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
404,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
404,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
404,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
405,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
405,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
405,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
405,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
406,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
406,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
406,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
406,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
407,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
408,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
408,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
409,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
409,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
409,3,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
409,4,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
409,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
410,1,Blister infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
410,2,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
411,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
412,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
413,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
414,1,Balanoposthitis,Penile and scrotal infections and inflammations,Male reproductive tract infections and inflammations,Repro,N
414,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
415,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
416,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
417,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
417,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
417,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
418,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
418,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
418,3,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
419,1,Device material issue,Device physical property and chemical issues,Device issues,Prod,N
419,2,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
420,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
421,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
421,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
421,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
421,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
422,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
422,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
423,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
424,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
425,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
425,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
425,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
426,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
426,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
426,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
426,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
427,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
427,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
427,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
427,4,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
428,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
428,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
428,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
428,4,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
428,5,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
428,6,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
429,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
430,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
431,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
432,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
432,2,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
432,3,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
433,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
433,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
433,3,Eyelid margin crusting,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
433,4,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
433,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
434,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
434,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
434,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
435,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
435,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
436,1,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
436,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
436,3,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
437,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
438,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
438,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
438,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
438,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
438,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
439,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
439,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
439,3,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
439,4,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
439,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
439,6,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
440,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
441,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
441,2,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
441,3,Tongue haemorrhage,Tongue disorders,Tongue conditions,Gastr,N
441,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
442,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
443,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
443,2,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
443,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
443,4,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
443,5,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
443,6,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
443,7,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
443,8,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
